Table 2.

Drug dosing for the endTB-Q experimental arm

Drug	Weight band (kg)
	24–30	> 30
Bedaquiline	200 mg daily for 2 weeks followed by 100 mg 3 × /week	400 mg daily × 2 weeks followed by 200 mg 3 × /week
Clofazimine	100 mg daily	100 mg daily
Delamanid	50 mg twice daily	100 mg twice daily
Linezolida	300 mg daily up to week 16 (followed by 300 mg daily or 600 mg 3 × /week)	600 mg daily up to week 16 (followed by 300 mg daily or 600 mg 3 × /week)

^aLinezolid dosing is routinely modified at week 16, or sooner if necessary, to reduce toxicity related to linezolid. The modification is either decreased (300 mg daily) or intermittent (600 mg 3 × /week) dosing as defined by a balanced secondary randomization